AAAAAA

   
Results: 1-10 |
Results: 10

Authors: Penzak, SR Lawhorn, WD Gubbins, PO
Citation: Sr. Penzak et al., Rapid and sensitive high-performance liquid chromatographic method for thedetermination of ritonavir in human plasma, INT J CL PH, 39(9), 2001, pp. 400-405

Authors: Penzak, SR Jann, MW Cold, JA Hon, YY Desai, HD Gurley, BJ
Citation: Sr. Penzak et al., Seville (sour) orange juice: Synephrine content and cardiovascular effectsin normotensive adults, J CLIN PHAR, 41(10), 2001, pp. 1059-1063

Authors: Penzak, SR Reddy, YS Grimsley, SR
Citation: Sr. Penzak et al., Depression in patients with HIV infection, AM J HEAL S, 57(4), 2000, pp. 376-386

Authors: McConnell, SA Penzak, SR Warmack, TS Anaissie, EJ Gubbins, PO
Citation: Sa. Mcconnell et al., Incidence of imipenem hypersensitivity reactions in febrile neutropenic bone marrow transplant patients with a history of penicillin allergy, CLIN INF D, 31(6), 2000, pp. 1512-1514

Authors: Penzak, SR Gubbins, PO Stratton, SL Anaissie, EJ
Citation: Sr. Penzak et al., Investigation of an outbreak of gram-negative bacteremia among hematology-oncology outpatients, INFECT CONT, 21(9), 2000, pp. 597-599

Authors: Penzak, SR Chuck, SK Stajich, GV
Citation: Sr. Penzak et al., Safety and efficacy of HMG-CoA reductase inhibitors for treatment of hyperlipidemia in patients with HIV infection, PHARMACOTHE, 20(9), 2000, pp. 1066-1071

Authors: Penzak, SR Chuck, SK
Citation: Sr. Penzak et Sk. Chuck, Hyperlipidemia associated with HIV protease inhibitor use: Pathophysiology, prevalence, risk factors and treatment, SC J IN DIS, 32(2), 2000, pp. 111-123

Authors: Gubbins, PO McConnell, SA Penzak, SR
Citation: Po. Gubbins et al., Antifungal agents, INFEC DIS S, 2000, pp. 185-217

Authors: Penzak, SR Grimsley, SR Jann, MW
Citation: Sr. Penzak et al., Significant interactions with new antiretrovirals and psychotropic drugs -Comment, ANN PHARMAC, 33(12), 1999, pp. 1372-1373

Authors: Penzak, SR Gubbins, PO Gurley, BJ Wang, PL Saccente, M
Citation: Sr. Penzak et al., Grapefruit juice decreases the systemic availability of itraconazole capsules in healthy volunteers, THER DRUG M, 21(3), 1999, pp. 304-309
Risultati: 1-10 |